Last reviewed · How we verify
Danlou Tablets
At a glance
| Generic name | Danlou Tablets |
|---|---|
| Also known as | Danlou |
| Sponsor | shuai Mao |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization (PHASE4)
- Danlou Tablets to Prevent Left Ventricular Remodeling (PHASE4)
- Clinical Study On The Relation Among Prescription, Syndrome and Disease of Turbid Phlegm and Blood Stasis for Coronary Heart Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |